What type of targeted drug does selinesol belong to?

Selinexor (Selinexor) is a new type of oral targeted therapy drug, which is mainly classified as a selective inhibitor of nuclear export (Selective Inhibitor of Nuclear Export, SINE) drugs. Its target is the nuclear export protein XPO1 (Exportin 1), which is overexpressed in a variety of malignant tumors and is closely related to the proliferation, anti-apoptosis and drug resistance of cancer cells. By inhibiting the function of XPO1, selinesol can effectively block the transport of tumor-related proteins from the nucleus to the cytoplasm and induce tumor cell apoptosis, thereby achieving anti-cancer effects.

Clinically, selinesol was initially approved for the treatment of relapsed or refractory multiple myeloma (RRMM), especially in patients who have become resistant to multiple lines of therapy. It is also used to treat hematological malignancies such as diffuse large Bcell lymphoma (DLBCL). Compared with traditional chemotherapy drugs, selinesol has the advantages of unique mechanism and clear target of action, and has shown high clinical value in combating highly drug-resistant tumors.

In addition, selinesol has also shown potential against solid tumors in multiple studies, such as pancreatic cancer, ovarian cancer, non-small cell lung cancer, etc. Multiple clinical trials are currently underway around the world to evaluate the effect of selinesol alone or in combination with other anti-tumor drugs in the treatment of different cancer types. Its extensive indication exploration also provides more possibilities for precision treatment in the future.

It should be noted that although selinesol has significant efficacy, it also has certain side effects, such as loss of appetite, fatigue, hyponatremia, etc. Therefore, patients should perform individualized dose adjustment and side effect management under the guidance of a doctor during use. Reasonable assessment of risks and benefits is the key to ensuring treatment effectiveness and safety.

Reference materials:https://www.selincro.com/